483
Granules Pharmaceuticals Inc.Granules Pharmaceuticals Inc. – FDA 483, Jun 27, 2025
Record Details
An FDA inspection of Granules Pharmaceuticals Inc. in Chantilly, VA, revealed a significant data integrity concern related to computer system controls. The firm was cited for not ensuring that changes to master production and control records are instituted only by authorized personnel. This issue stems from the use of shared login credentials and the ability of users to modify system date and time settings on laboratory computers.
View Company Profile
ID · ff217be2-7175-40cb-a94a-9d59b9094abe
Other documents for Granules Pharmaceuticals Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.